Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Endo Int'l Plc (ENDP)

Endo Int'l Plc (ENDP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 938,853
  • Shares Outstanding, K 226,776
  • Annual Sales, $ 2,947 M
  • Annual Income, $ -1,031,470 K
  • 60-Month Beta 1.41
  • Price/Sales 0.32
  • Price/Cash Flow 0.66
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.57
  • Number of Estimates 7
  • High Estimate 0.59
  • Low Estimate 0.55
  • Prior Year 0.75
  • Growth Rate Est. (year over year) -24.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.32 +29.22%
on 10/14/19
5.18 -17.18%
on 10/18/19
+0.59 (+15.79%)
since 10/11/19
3-Month
1.97 +117.77%
on 09/05/19
5.18 -17.18%
on 10/18/19
+1.82 (+73.68%)
since 08/13/19
52-Week
1.97 +117.77%
on 09/05/19
13.64 -68.55%
on 11/14/18
-9.23 (-68.27%)
since 11/13/18

Most Recent Stories

More News
Endo (ENDP) Q3 Earnings & Revenues Beat Estimates, Down Y/Y

Endo (ENDP) reports better-than-expected results for the third quarter as Xiaflex delivers a strong performance.

LCI : 9.04 (+0.67%)
FGEN : 34.58 (-2.76%)
ENDP : 4.29 (+3.62%)
PTLA : 27.37 (-1.12%)
Endo International Plc to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 5, 2019 / Endo International Plc (NASDAQ: ) will be discussing their earnings results in their 2019 Third Quarter Earnings to be held on November 5, 2019 at 7:30 AM...

ENDP : 4.29 (+3.62%)
Endo International (ENDP) Q3 Earnings and Revenues Top Estimates

Endo (ENDP) delivered earnings and revenue surprises of 13.21% and 3.09%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

ENDP : 4.29 (+3.62%)
Endo Reports Third-Quarter 2019 Financial Results

- Operating Performance Led by Year-over-Year Double-Digit-Percentage Revenue Growth in Sterile Injectables and in Specialty Products Portfolio of Branded Pharmaceuticals -

ENDP : 4.29 (+3.62%)
Endo Implements CEO Succession Plan

Paul Campanelli Appointed Chairman of the Board, Will Also Continue as President and Chief Executive Officer Until Successor Appointed; Roger Kimmel Appointed Senior Independent Director

ENDP : 4.29 (+3.62%)
Earnings Preview: Endo International (ENDP) Q3 Earnings Expected to Decline

Endo (ENDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ENDP : 4.29 (+3.62%)
Endo Aesthetics Launches New Campaign Elevating Artistry Through Scientific Innovation

Endo International plc (NASDAQ: ENDP) announced that Endo Aesthetics launched a "Redefining Scientific Artistry" campaign at the Annual Meeting of the American Society for Dermatologic Surgery (ASDS) held...

ENDP : 4.29 (+3.62%)
Endo Presents New XIAFLEX® (collagenase clostridium histolyticum) Data at the 2019 Fall Meeting of the Sexual Medicine Society of North America (SMSNA)

Endo International plc (NASDAQ: ENDP) today announced that five new studies of XIAFLEX® (collagenase clostridium histolyticum) for the treatment of Peyronie's disease will be presented as poster presentations...

ENDP : 4.29 (+3.62%)
Endo Presents Data on the Use of a Standing MRI for the Evaluation of Cellulite at the American Society for Dermatologic Surgery (ASDS) Annual Meeting

Endo International plc (NASDAQ: ENDP) today announced that it will present data on the use of a standing MRI as compared to prone MRI for the evaluation of cellulite at the upcoming Annual Meeting of the...

ENDP : 4.29 (+3.62%)
Movapo® (apomorphine hydrochloride) for Patients with Advanced Parkinson's Disease Now Reimbursed in Most Canadian Provinces

Paladin Labs Inc., a subsidiary of Endo International plc (NASDAQ: ENDP), today announced that patients diagnosed with advanced Parkinson's disease (PD) living in Alberta, Manitoba, New Brunswick, Nova...

ENDP : 4.29 (+3.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade ENDP with:

Business Summary

Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova,...

See More

Key Turning Points

2nd Resistance Point 4.54
1st Resistance Point 4.42
Last Price 4.29
1st Support Level 4.10
2nd Support Level 3.90

See More

52-Week High 13.64
Fibonacci 61.8% 9.18
Fibonacci 50% 7.81
Fibonacci 38.2% 6.43
Last Price 4.29
52-Week Low 1.97

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar